statistiche ricercatore

Continente	#
NA - Nord America	532
EU - Europa	441
AS - Asia	279
SA - Sud America	31
AF - Africa	13
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.300

Nazione	#
US - Stati Uniti d'America	520
SG - Singapore	104
RU - Federazione Russa	102
CN - Cina	83
IT - Italia	72
FI - Finlandia	45
VN - Vietnam	40
DE - Germania	38
SE - Svezia	34
UA - Ucraina	32
BR - Brasile	23
FR - Francia	23
PL - Polonia	23
IE - Irlanda	17
GB - Regno Unito	12
BG - Bulgaria	11
TR - Turchia	11
IN - India	10
RO - Romania	9
PT - Portogallo	8
CA - Canada	7
JP - Giappone	7
ZA - Sudafrica	6
HK - Hong Kong	4
ES - Italia	3
ID - Indonesia	3
MA - Marocco	3
NL - Olanda	3
AU - Australia	2
BD - Bangladesh	2
CH - Svizzera	2
CL - Cile	2
EC - Ecuador	2
ET - Etiopia	2
GR - Grecia	2
IQ - Iraq	2
JM - Giamaica	2
MY - Malesia	2
PK - Pakistan	2
PY - Paraguay	2
A2 - ???statistics.table.value.countryCode.A2???	1
AR - Argentina	1
AZ - Azerbaigian	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
GT - Guatemala	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
KR - Corea	1
LK - Sri Lanka	1
LT - Lituania	1
MD - Moldavia	1
MX - Messico	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PE - Perù	1
PH - Filippine	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TG - Togo	1
TW - Taiwan	1
Totale	1.300

Nome	#
Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An In Vitro Electron Paramagnetic Resonance Study	198
Physical interactions between marine phytoplankton and PET plastics in seawater.	181
Electron paramagnetic resonance applications: from drug discovery to marine biology studies	176
Metallodendrimers as a promising tool in the biomedical field: An overview	157
Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR	138
Elaborated study of Cu (II) carbosilane metallodendrimers bearing substituted iminopyridine moieties as antitumor agents	134
DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes	133
Insight into the antitumor activity of carbosilane Cu( )–metallodendrimers through their interaction with biological membrane models	116
Synthesis and biological and physico-chemical characterization of glycodendrimers and oligopeptides for the treatment of systemic lupus erythematosus	99
Totale	1.332

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	65	0	0	0	0	0	0	0	0	0	11	27	27
2021/2022	110	13	3	9	12	0	4	5	7	5	10	5	37
2022/2023	186	19	22	8	33	13	32	0	8	32	4	7	8
2023/2024	73	12	4	4	12	4	19	1	4	0	8	2	3
2024/2025	274	14	6	31	13	20	23	51	8	23	25	47	13
2025/2026	406	36	34	32	60	37	50	38	22	47	50	0	0
Totale													1.332